Old Web
English
Sign In
Acemap
>
Paper
>
High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer
High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer
2021
Marta Palafox
Laia Monserrat
Meritxell Bellet
Guillermo Villacampa
Abel Gonzalez-Perez
Mafalda Oliveira
Fara Brasó Maristany
Nusaibah Ibrahimi
Srinivasaraghavan Kannan
Leonardo Mina
Maria Teresa Herrera-Abreu
Andreu Òdena
Monica Sanchez-Guixé
Marta Capelan
Analia Azaro
Alejandra Bruna
Olga Graciela Cantú-Rodríguez
M. Guzmán
Judit Grueso
Cristina Viaplana
Javier Hernández Losa
Faye Su
Kui Lin
Robert Clarke
Carlos Caldas
Arribas Joaquín
Stefan Michiels
Alicia García Sanz
Nicholas C. Turner
Aleix Prat
P Nuciforo
Rodgrigo Dienstmann
Chandra S. Verma
Nuria Lopez-Bigas
M. Scaltriti
Monica Arnedos
Cristina Saura
Violeta Serra
Keywords:
er breast cancer
Cancer research
Biomarker (medicine)
inhibitor resistance
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]